21.81
+0.11(+0.51%)
Currency In USD
Address
2656 State Street
Carlsbad, CA 92008
United States of America
Phone
619 728 4760
Website
Sector
Healthcare
Industry
Biotechnology
Employees
60
First IPO Date
September 15, 2021
| Name | Title | Pay | Year Born |
| Dr. Todd Harris Ph.D. | Co-Founder, President, Chief Executive Officer, Secretary, Treasurer & Director | 1.07M | 1979 |
| Dr. Ronald V. Swanson Ph.D. | Chief Scientific Officer | 536,188 | 1963 |
| Dr. Douglas Warner M.D. | Chief Medical Officer | 627,900 | 1972 |
| Mr. Ali D. Fawaz J.D. | General Counsel | 629,230 | N/A |
| Mr. Daniel Bensen | Co-Founder & Chief Operating Officer | 737,643 | 1975 |
| Mr. Alan Fuhrman CPA | Chief Financial Officer | 763,093 | 1957 |
| Ms. Sarah Honig | Senior Vice President of Corporate Development & Strategy | 0 | N/A |
| Liz Pagano | Senior Vice President of Human Resources | 0 | N/A |
| Dr. Robert L. Hudkins Ph.D. | Chief Technology Officer | 0 | 1955 |
| Dr. Piyush R. Patel Ph.D. | Chief Development Officer | 0 | 1965 |
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.